Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Electroconvulsive therapy improves clinical manifestations of treatment-resistant depression without changing serum BDNF levels
Chiara Rapinesi, Georgios D. Kotzalidis, Martina Curto, et al.
Psychiatry Research (2015) Vol. 227, Iss. 2-3, pp. 171-178
Closed Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

How Electroconvulsive Therapy Works?: Understanding the Neurobiological Mechanisms
Amit Singh, Sujita Kumar Kar
Clinical Psychopharmacology and Neuroscience (2017) Vol. 15, Iss. 3, pp. 210-221
Open Access | Times Cited: 153
Serum BDNF as a peripheral biomarker of treatment-resistant depression and the rapid antidepressant response: A comparison of ketamine and ECT
Andrew P. Allen, M. Naughton, Joshua L. Dowling, et al.
Journal of Affective Disorders (2015) Vol. 186, pp. 306-311
Closed Access | Times Cited: 125
Relationship Between Hippocampal Volume, Serum BDNF, and Depression Severity Following Electroconvulsive Therapy in Late-Life Depression
Filip Bouckaert, Annemiek Dols, Louise Emsell, et al.
Neuropsychopharmacology (2016) Vol. 41, Iss. 11, pp. 2741-2748
Open Access | Times Cited: 94
Brain-Derived Neurotrophic Factor (BDNF) as a biomarker of treatment response in patients with Treatment Resistant Depression (TRD): A systematic review & meta-analysis
Shakila Meshkat, Yazen Alnefeesi, Muhammad Youshay Jawad, et al.
Psychiatry Research (2022) Vol. 317, pp. 114857-114857
Closed Access | Times Cited: 45
Brain-Derived Neurotrophic Factor (BDNF) as a Predictor of Treatment Response in Major Depressive Disorder (MDD): A Systematic Review
Mario Ignacio Zelada, Verónica Garrido, Andrés Liberona, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14810-14810
Open Access | Times Cited: 26
International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological Targets
Filippo Caraci, Francesca Calabrese, Raffaella Molteni, et al.
Pharmacological Reviews (2018) Vol. 70, Iss. 3, pp. 475-504
Open Access | Times Cited: 57
Increased serum brain-derived neurotrophic factor levels following electroconvulsive therapy or antipsychotic treatment in patients with schizophrenia
J. Li, F. Ye, Wenhuan Xiao, et al.
European Psychiatry (2016) Vol. 36, pp. 23-28
Closed Access | Times Cited: 48
BDNF blood levels after electroconvulsive therapy in patients with mood disorders: An updated systematic review and meta-analysis
Rebeca Pelosof, Leonardo Afonso dos Santos, Luís C. Farhat, et al.
The World Journal of Biological Psychiatry (2022) Vol. 24, Iss. 1, pp. 24-33
Closed Access | Times Cited: 19
Mapping Electroconvulsive Therapy Induced Neuroplasticity: Towards a Multilevel Understanding of the Available Clinical Literature – A Scoping Review
Maarten Laroy, Louise Emsell, Mathieu Vandenbulcke, et al.
Neuroscience & Biobehavioral Reviews (2025), pp. 106143-106143
Closed Access
Premedication effect of dexmedetomidine and alfentanil on seizure time, recovery duration, and hemodynamic responses in electroconvulsive therapy
Esmail Moshiri, Hesameddin Modir, Niknam Bagheri, et al.
Annals of Cardiac Anaesthesia (2016) Vol. 19, Iss. 2, pp. 263-263
Open Access | Times Cited: 35
Brain-derived neurotrophic factor blood levels after electroconvulsive therapy in patients with major depressive disorder: A systematic review and meta-analysis
Shuxin Luan, Bing Zhou, Qiong Wu, et al.
Asian Journal of Psychiatry (2020) Vol. 51, pp. 101983-101983
Closed Access | Times Cited: 32
The effect of antidepressant treatment on blood BDNF levels in depressed patients: A review and methodological recommendations for assessment of BDNF in blood
Clara Aabye Madsen, Miriam L. Navarro, Betina Elfving, et al.
European Neuropsychopharmacology (2024) Vol. 87, pp. 35-55
Closed Access | Times Cited: 3
The Serum Brain-Derived Neurotrophic Factor Increases in Serotonin Reuptake Inhibitor Responders Patients with First-Episode, Drug-Naïve Major Depression
Reiji Yoshimura, Naomichi Okamoto, Enkhmurun Chibaatar, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 584-584
Open Access | Times Cited: 8
Remission of depression following electroconvulsive therapy (ECT) is associated with higher levels of brain-derived neurotrophic factor ( BDNF)
Thiago Fernando Vasconcelos Freire, Marcelo Pio de Almeida Fleck, Neusa Sica da Rocha
Brain Research Bulletin (2016) Vol. 121, pp. 263-269
Open Access | Times Cited: 25
Clinical Improvement in Depression and Cognitive Deficit Following Electroconvulsive Therapy
Ahmad Mus’ab Ahmad Hariza, Mohd Heikal Mohd Yunus, Jaya Kumar Murthy, et al.
Diagnostics (2023) Vol. 13, Iss. 9, pp. 1585-1585
Open Access | Times Cited: 6
Effect of electroconvulsive therapy on brain‐derived neurotrophic factor levels in patients with major depressive disorder
Annamari Sorri, Kaija Järventausta, Olli Kampman, et al.
Brain and Behavior (2018) Vol. 8, Iss. 11
Open Access | Times Cited: 18
<p>BDNF and the Antidepressant Effects of Ketamine and Propofol in Electroconvulsive Therapy: A Preliminary Study</p>
Xingbing Huang, Xiong Huang, Hongbo He, et al.
Neuropsychiatric Disease and Treatment (2020) Vol. Volume 16, pp. 901-908
Open Access | Times Cited: 15
A Systematic Review of Neuromodulation Treatment Effects on Suicidality
Mehmet Utku Küçüker, Ammar Almorsy, Ayse Irem Sonmez, et al.
Frontiers in Human Neuroscience (2021) Vol. 15
Open Access | Times Cited: 13
Both Serum Brain-Derived Neurotrophic Factor and Interleukin-6 Levels Are Not Associated with Therapeutic Response to Lamotrigine Augmentation Therapy in Treatment-Resistant Depressive Disorder
Shoko Kagawa, Kazuo Mihara, Takeshi Suzuki, et al.
Neuropsychobiology (2017) Vol. 75, Iss. 3, pp. 145-150
Closed Access | Times Cited: 14
Tipepidine, a non-narcotic antitussive, exerts an antidepressant-like effect in the forced swimming test in adrenocorticotropic hormone-treated rats
Kazuaki Kawaura, Yukino Ogata, Sokichi Honda, et al.
Behavioural Brain Research (2015) Vol. 302, pp. 269-278
Closed Access | Times Cited: 10
Serum BDNF levels and the antidepressant effects of electroconvulsive therapy with ketamine anaesthesia: a preliminary study
Wei Zheng, Qiao-Mei Cen, Sha Nie, et al.
PeerJ (2021) Vol. 9, pp. e10699-e10699
Open Access | Times Cited: 10
A comparative study of the effect of electroconvulsive therapy and transcranial direct current stimulation in the treatment of persons suffering from treatment-resistant depression
Vikhram Ramasubramanian, S. Mathumathi, Gopi Rajendhiran, et al.
Industrial Psychiatry Journal (2022) Vol. 31, Iss. 1, pp. 68-73
Open Access | Times Cited: 7
The ratio and interaction between neurotrophin and immune signaling during electroconvulsive therapy in late-life depression
Dore Loef, Kristof Vansteelandt, Mardien L. Oudega, et al.
Brain Behavior & Immunity - Health (2021) Vol. 18, pp. 100389-100389
Open Access | Times Cited: 7
Antidepressants Promote and Prevent Cancers
Francis Lavergne, Thérèse M. Jay
Cancer Investigation (2020) Vol. 38, Iss. 10, pp. 572-598
Closed Access | Times Cited: 6
L’électroconvulsivothérapie en psychiatrie et neurologie
J. Daaboul, Ali Amad
Pratique Neurologique - FMC (2019) Vol. 10, Iss. 3, pp. 154-161
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top